切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2019, Vol. 08 ›› Issue (04) : 377 -382. doi: 10.3877/cma.j.issn.2095-3224.2019.04.010

所属专题: 文献

论著

以IL-1β为基础的腹腔不同免疫水平对直肠癌术后腹腔微转移灶转归的作用
鲁兵1,(), 张振宇1, 倪荔1, 严东羿1, 朱哲1, 高玮1, 袁彪1, 杨颻1, 傅传刚1   
  1. 1. 200120 上海,同济大学附属东方医院胃肠肛肠外科
  • 收稿日期:2018-01-23 出版日期:2019-08-25
  • 通信作者: 鲁兵
  • 基金资助:
    上海市卫计委局级项目(No.201440305); 上海市科委科研项目(No.19411966500)

Effect of IL-1β based intraperitoneal immunity levels on the prognosis of intraperitoneal micrometastasis after rectal cancer operation

Bing Lu1,(), Zhenyu Zhang1, Li Ni1, Dongyu Yan1, Zhe Zhu1, Wei Gao1, Biao Yuan1, Yao Yang1, Chuangang Fu1   

  1. 1. Department of General Surgery, East Hospitail, Tongji University, Shanghai 200120, China
  • Received:2018-01-23 Published:2019-08-25
  • Corresponding author: Bing Lu
  • About author:
    Corresponding author: Lu Bing, Email,
引用本文:

鲁兵, 张振宇, 倪荔, 严东羿, 朱哲, 高玮, 袁彪, 杨颻, 傅传刚. 以IL-1β为基础的腹腔不同免疫水平对直肠癌术后腹腔微转移灶转归的作用[J/OL]. 中华结直肠疾病电子杂志, 2019, 08(04): 377-382.

Bing Lu, Zhenyu Zhang, Li Ni, Dongyu Yan, Zhe Zhu, Wei Gao, Biao Yuan, Yao Yang, Chuangang Fu. Effect of IL-1β based intraperitoneal immunity levels on the prognosis of intraperitoneal micrometastasis after rectal cancer operation[J/OL]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2019, 08(04): 377-382.

目的

探讨IL-1β介导的腹腔内免疫功能变化对直肠癌腹腔微转移的影响。

方法

原代分离人腹膜间皮细胞,采用免疫荧光鉴定vimentin和VWF的表达,采用不同浓度的IL-1β和不同浓度的IL-1β抗体刺激共培养的人腹膜间质内皮细胞和癌细胞,流式细胞数检测细胞的粘附率。

结果

免疫荧光鉴定得出:vimentin为阳性表达,VWF为阴性表达,随着IL-1β浓度的增加,细胞粘附率依次增加;当加入抗体IL-1β后,随着抗体浓度的增加,人腹膜间质内皮细胞与癌细胞粘附率呈现下降趋势。且5 ng/mL的IL-1β含量时,细胞粘附率最高,显著高于其他组(P<0.05);10 ng/mL的IL-1β含量时粘附率高于其他组,仅低于5 ng/mL的IL-1β组;加入抗体IL-1β后所有组别的粘附率趋势与不加前一致,但是所有组别的粘附率均降低,1 ng/mL IL-1β组+0.1ug/mL抗体组和5 ng/mL IL-1β组+0.5 ug/mL抗体组的细胞粘附率最高,阴性对照组细胞粘附率最低,显著低于其他组(P<0.05)。

结论

本研究显示IL-1β能够促进直肠癌细胞与腹膜间皮细胞粘附,并呈现浓度依耐性,提示其可能参与直肠癌腹膜转移。

Objective

To investigate the effect of L-1β-mediated intraperitoneal immune function on peritoneal micrometastasis in rectal cancer.

Methods

Primary human peritoneal mesothelial cells were isolated and the expressions of vimentin and VWF were detected by immunofluorescence. Human peritoneal mesothelial cells and cancer cells were stimulated with different concentrations of IL-1β and IL-1β antibody. The rate of cell adhesion was detected by flow cytometry.

Results

The results of immunofluorescence showed that vimentin was positive and VWF was negative. With the increase of IL-1β, cell adhesion rate were increasing. When IL-1β was added, with the increase of antibody concentration, human peritoneal interstitial endothelial cells and cancer cell adhesion rate showed declining trend. When the concentration of IL-1β was 5 ng/mL, the cell adhesion rate was the highest, which was significantly higher than that of other groups (P<0.05). The adhesion rate trend of all the groups after adding IL-1β antibody was the same as that of the other groups, but the adhesion rate of all groups was decreased. The adhesion rate of 1 ng/mL IL-1β+ 0.1 ug/mL and 5 ng/mL IL-1β group+ 0.5 ug/mL antibody group were the highest, and the lowest in the negative control group (P<0.05).

Conclusion

Our results show that IL-1β promotes the adhesion of rectal cancer cells to peritoneal interstitial endothelial cells in a concentration-dependent manner, indicating a favorable role of IL-1β in peritoneal carcinomatosis.

图1 人腹膜间皮细胞原代培养照片。1A:第1天,1B:第3天,1C:第5天,1D:第9天,1E:P1代,1F:P2代(×100倍)
图2 原代培养人腹膜间皮细胞鉴定结果。2A:DAPI染色,2B:Vimentin染色,2C:Merge,2D:DAPI染色,2E:VWF染色,2F:Merge (×100倍)
图3 各实验组流式细胞检测结果。3A:阴性对照组,3B:0 ng/mL IL-1β组,3C:1 ng/mL IL-1β组,3D:5 ng/mL IL-1β组,3E:10 ng/mL IL-1β组,3F:0 ng/mL IL-1β+0 μg/mL抗体组,3G:1 ng/mL IL-1β+0.1 μg/mL抗体组,3H:5 ng/mL IL-1β+0.5 μg/mL抗体组,3I:5 ng/mL IL-1β+1 μg/mL抗体组
图4 各实验组细胞的粘附率结果
[1]
朱振宇,郭洪亮. CD68和CK20与大肠癌微转移的研究进展[J]. 中华肿瘤防治杂志, 2011, 18(24): 1973-1975.
[2]
李正东,陈本鑫,吴德平, 等. Ⅱ、Ⅲ期结肠癌患者根治术后肿瘤转移复发的相关因素分析[J]. 海南医学, 2014, 25(10): 1415-1417, 1418.
[3]
Takata A, Kurokawa Y, Fujiwara Y, et al. Prognostic value of CEA and CK20 Mrna in theperitoneal lavage fluid of patients undergoing curative surgery for gastric cancer [J]. World J Surg, 2014, 38(5): 1107-111.
[4]
厚象,潘凯,芮景, 等. 腹腔镜结直肠癌根治术对肿瘤微转移影响的临床研究[J]. 中国内镜杂志, 2009, 15(5): 458-461.
[5]
Khare V, Paul G, Movadat O, et al. IL1 0R 2 overexpression promotes IL22/STAT3 signaling in colorectal carcinogenesis [J]. Cancer Immunol Res, 2015, 3(11): 1227-1235.
[6]
Zhang S, Fujita H, Mitsui H, et al. Increased Tc22 and Treg/CD8 ratio contribute to aggressive growth of transplant associated squamous cell carcinoma [J]. PLoS One, 2013, 8(5): e62154.
[7]
Arend WP. The balance between IL-1 and IL-1Ra in disease[J]. Cytokine Growth Factor Rev, 2002, 13:323-340.
[8]
GrazianoF, Ruzzo A, Canestrari E, et al. Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer [J]. The Pharmacogenomics Journal, 2009, 9(1): 78-84.
[9]
Apte RN, Voronov E. Interleukin-1-a major pleiotropic cytokine in tumor-host interactions [J]. Semin Cancer Biol, 2002, 12(4): 277-290.
[10]
Lahm H, Schindel M, Frikart L, et al. Selective suppression of cytokine secretion in whole blood cell cultures of patients with colorectal cancer [J]. Brish Joumal of Carcer, 1998, 78(8): 1018-1023.
[11]
Allan SM, Tyrrell PJ, Rothwell NJ. Interleukin-1 and neuronal injury [J]. Nat Rev Immunol, 2005, 5(8): 629-640.
[12]
Cheong YC, Larid SM, Li TC, et al. Peritoneal healing andadhesion formation reformation [J]. Hum Reprod Update, 2001, 7(6): 556-566.
[13]
冉擘力,司良毅,何国祥. 白介素-1β预处理对心肌细胞粘附分子表达的影响[J]. 解放军医学杂志, 2002, 27(2): 155-156. .
[14]
Rusai K, Huang H, Sayed N, et al. Administration of interleukin-1 receptor antagonist ameliorates renal ischemia-reperfusion injury [J]. Transpl Int, 2008, 21(6): 572-580.
[15]
Van Grevenstein WM, Hofland LJ, van Rossen ME, et al. Inflammatory cytokines stimulate the adhesion of colon carcinoma cells to mesothelial monolayers [J]. Dig Dis Sci, 2007, 52(10): 2775-2783.
[16]
Cole AM, Jackson JE, Doescher M. Urban-rural disparities in colorectal cancer screening: cross-sectional analysis of 1998~2005 data from the centers for disease control′s behavioral risk factor surveillance study [J]. Cancer Medicine, 2012, 1(3): 350-356.
[17]
蔡建强. 重视胃肠道恶性肿瘤的综合治疗[J]. 中国综合临床, 2010, 26(4): 337-338.
[18]
Spiliotis J, Datsis A. The surgical approach to locally recurrentrectal cancer [J]. Techcoloproctol, 2004, 8(suppl 1): s33-35.
[19]
Gungerson LL, Sargent DJ, Tepper JE, et al. Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis [J]. J Clin Oncol, 2004, 22(10): 1785-1796.
[20]
Fujita S, Shimoda T, Yoshimura K, et al. Prospective evaluation of prognostic factors in patients with colorectal cancer undergoing curative resection [J]. J S urgoncal, 2003, 84(3): 127-131.
[21]
Neki K, Eto K, Kosuge M, et al. Comparison of postoperative outcomes between laparoscopic and open surgery for colorectal cancer [J]. Anticancer Res, 2017, 37(9): 5173-5177.
[22]
Veldkamp R, Kuhry E, Hop WC, et al. Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes o f a randomised trial [J]. Lancet Oncol 2005, 6(7): 477-484.
[23]
van der Pas MH, Haglind E, Cuesta MA, et al. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of arandomised, phase 3 trial [J]. Lancet Oncol 2013, 14(3): 210-218.
[24]
Loffer FD, P ent D. Laparoscopy in the obese patient [J]. Am J O bstet Gynecol 1976, 125(1): 104-107.
[25]
Tekkis PP, Senago re AJ, D elaney CP, et al. Evaluation of the learning curve in laparoscopic colorectal surgery: comparison of right-sided and left-sided resections [J]. Ann Surg 2005, 242(1): 83-91.
[26]
Du J, Yu PW, Tang B. Application of stereology to study the effects of pneumoperitoneum on peritoneum [J]. Surg Endosc, 2011, 25(2): 619-627.
[27]
汤雪峰,李财宝,刘岗, 等. 腹腔镜微创手术与传统开腹手术对结直肠癌患者免疫和生理功能影响的临床观察[J]. 标记免疫分析与临床, 2015, 22(4): 278-281.
[28]
Kusano T, Inomata M, Hiratsuka T, et al. A comparison of laparoscopic and open surgery following preoperative chemoradiation therapy for locally advanced lower rectal cancer [J]. Jpn J Clin Oncol, 2014, 44(4): 305-310.
[29]
于歌,唐波,余佩武, 等. 腹腔镜与开腹胃癌手术腹腔冲洗液中IL-1β浓度的变化及其对腹膜间皮细胞与胃癌细胞黏附的影响[J]. 解放军医学杂志, 2010, 35(1): 28-31.
[1] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[2] 吴晖, 佴永军, 施雪松, 魏晓为. 两种解剖入路下行直肠癌侧方淋巴结清扫的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 40-43.
[3] 周世振, 朱兴亚, 袁庆港, 刘理想, 王凯, 缪骥, 丁超, 汪灏, 管文贤. 吲哚菁绿荧光成像技术在腹腔镜直肠癌侧方淋巴结清扫中的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 44-47.
[4] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[5] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[6] 庄宝雄, 邓海军. 单孔+1腹腔镜直肠癌侧方淋巴结清扫术[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 601-601.
[7] 郑民华, 蒋天宇, 赵轩, 马君俊. 中国腹腔镜直肠癌根治术30年发展历程与未来[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 591-595.
[8] 池畔, 黄胜辉. 中国腹腔镜直肠癌根治术30年来的巨大进步[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 596-600.
[9] 李明, 屠松, 闫鹏, 钱军, 高鹏程, 许文山, 杨发英, 胡振涛, 单永玮. 应用前列腺电切镜引导置管治疗直肠低位吻合口漏研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 603-606.
[10] 李玲, 刘亚, 李培玲, 张秀敏, 李萍. 直肠癌患者术后肠道菌群的变化与抑郁症相关性研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 607-610.
[11] 赵梓竣, 兰运升. 改良一针法末端回肠造口术对低位直肠癌保肛术后应激反应及安全性的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 611-614.
[12] 吴胜伟, 王志伟, 陈贵进, 刘序, 吴晓翔. 系膜肥厚低位直肠癌患者改良NOSES Ⅰ式手术的临床效果评价[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 615-618.
[13] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[14] 梁轩豪, 李小荣, 李亮, 林昌伟. 肠梗阻支架置入术联合新辅助化疗治疗结直肠癌急性肠梗阻的疗效及其预后的Meta 分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 472-482.
[15] 严虹霞, 王晓娟, 张毅勋. 2 型糖尿病对结直肠癌患者肿瘤标记物、临床病理及预后的影响[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 483-487.
阅读次数
全文


摘要